Table 1 of Bessho, Mol Vis 2011; 17:977-982.

Table 1. Clinical details of the typical neovascular age-related macular degeneration (tAMD) patients stratified by the genotype of rs10490924 in the age-related maculopathy susceptibility 2 (ARMS2) gene.

n=68 G/G G/T T/T P
Gender (female/male) 0/8 9/25 6/20 0.26†
Age (mean±SD, years) 76±5 76±6 76±8 0.87*
GLD (mean±SD, μm) 3063±972 3358±1206 3950±1715 0.37*
Number of PDT sessions/year (mean±SD) 1.6±0.9 1.9±1.0 2.1±1.0 0.57*
Baseline BCVA log MAR (mean±SD) 0.87±0.51 0.76±0.36 0.78±0.42 0.96*
12Mo BCVA log MAR (mean±SD) 0.66±0.40 0.84±0.49 1.03±0.39 0.09*
12Mo-Baseline BCVA log MAR (mean±SD) −0.21±0.32 0.07±0.51 0.25±0.42 0.01*

Abbreviations: GLD represents greatest linear dimension, PDT represents photodynamic therapy, BCVA represents best-corrected visual acuity, Mo represents month. † χ2 test, * Kruskal–Wallis test.

Bessho, Mol Vis 2011; 17:977-982. http://www.molvis.org/molvis/v17/a108

©2011 Molecular Vision http://www.molvis.org/molvis/

ISSN 1090-0535